Note: This document is a translation of a part of the original Japanese version and provided for reference purposes only. In the event of any discrepancy
between the Japanese original and this English translation, the Japanese original shall prevail.

Consolidated Financial Results
for the Nine Months Ended December 31, 2023
[Japanese GAAP]
February 13, 2024
Company name: SUNCORPORATION
Stock exchange listing: Tokyo
Code number: 6736
URL: https://www.sun-denshi.co.jp
Representative: Ryusuke Utsumi
President and Representative Director
Contact: Yoshimi Kimura
Representative and Executive managing directorPhone: +81-52-756-5981
Scheduled date of filing quarterly securities report: February 13, 2024
Scheduled date of commencing dividend payments: Availability of supplementary briefing material on quarterly financial results: No
Schedule of quarterly financial results briefing session: No(Amounts of less than one million yen are rounded down.)
1. Consolidated Financial Results for the Nine Months Ended December 31, 2023 (April 1, 2023 to December 31, 2023)(1) Consolidated Operating Results(% indicates changes from the previous corresponding period.)
Profit attributable toNet sales
Operating profit
Ordinary profit
owners of parent
Millions of yen% Millions of yen% Millions of yen% Millions of yen%
Nine months ended
December 31, 2023
7,467
(78.4)
218(4,267)(4,145)
December 31, 2022
34,49731.1(1,874)
13,566
322.3
6,305
321.2
(Note) Comprehensive income:Nine months ended December 31, 2023: ¥(176) million [-%]
Nine months ended December 31, 2022: ¥11,959 million [273.5%]
Basic earnings
per share

Diluted earnings pershare

Yen
Yen
Nine months ended
December 31, 2023
(186.29)
December 31, 2022
266.28252.09(Note) Diluted net income per share for the third quarter of the fiscal year ending March 31, 2024 is not shown in the above table, because
net income per share was negative although there are residual shares.

(2) Consolidated Financial Position
Total assets

Net assets

Capital adequacy ratio

Millions of yen
Millions of yen%
As ofDecember 31, 2023
42,19033,51979.2
March 31, 2023
41,76735,013
83.6(Reference) Equity: As of December 31, 2023:¥33,406 million
As of March 31, 2023:¥34,908 million(Note) In the first quarter of the current fiscal year, the Company finalized the provisional accounting treatment for the businesscombination, and the consolidated financial position for the fiscal year ending March 31, 2023 reflects the details of the finalization ofthe provisional accounting treatment..

―1―2. Dividends
Annual dividends
3rdquarter-end

1stquarter-end

2ndquarter-end

Yen

Yen

Yen

Yen

Yen

Fiscal year ended March 31, 2023

-0.00

-

20.00

20.00

Fiscal year ending March 31, 2024

-

0.00

40.00

40.00

Fiscal year ending March 31, 2024(Forecast)(Note) Revision to the forecast for dividends announced most recently:

Year-end

TotalNo

3. Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2024(April 1, 2023 to March 31, 2024)(% indicates changes from the previous corresponding period.)
Net sales
Millions of yen

Operating profit%

Millions of yen

10,000(73.3)
10Full year～11,000～(70.6)～100(Note) Revision to the financial results forecast announced most recently:
No%-It is difficult to reasonably estimate the impact of changes in the fair value of contingent consideration, certain restricted stock andderivative warrant liabilities of our equity method investment Cellebrite DI Ltd. The Company has not yet determined the fair value ofthe restricted stock and derivative warrant liability.
* Notes:(1) Changes in significant subsidiaries during the nine months ended December 31, 2023
(changes in specified subsidiaries resulting in changes in scope of consolidation):No(2) Accounting policies adopted specially for the preparation of quarterly consolidated financial statements:

No(3) Changes in accounting policies, changes in accounting estimates and retrospective restatement
1) Changes in accounting policies due to the revision of accounting standards: No
2) Changes in accounting policies other than 1) above: No
3) Changes in accounting estimates: No4) Retrospective restatement: No(4) Total number of issued shares (common shares)
1) Total number of issued shares at the end of the period (including treasury shares):December 31, 2023:
24,007,728 shares
March 31, 2023:
23,998,828 Shares
2) Number of treasury shares at the end of the period:
December 31, 2023:
1,793,177 sharesMarch 31, 2023:
1,366,387 Shares
3) Average number of shares outstanding during the period:
Nine months ended December 31, 2023:
Nine months ended December 31, 2022:※※

22,253,162 shares
23,681,288 shares

Quarterly financial statements are not subject to a quarterly review by a certified public accountant or firm of accountants.
Explanation of the appropriate use of earnings guidance and other special disclosures
The forward-looking statements in this document, including earnings guidance, are based on information currently available
to the Company and certain assumptions that the Company believes are reasonable. Actual results could differ materially as aresult of various factors.

―2―